Impact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeria

ABSTRACT

Background: Diabetes mellitus is a chronic, degenerative disease, requiring a multi-dimensional, multi-professional care by healthcare providers and substantial self-care by the patients, to achieve treatment goals. Objective: To evaluate the impact of pharmacist-led care on glycaemic control in patients with uncontrolled Type 2 Diabetes. Methods: In a parallel group, single-blind randomised controlled study; type 2 diabetic patients, with greater than 7% glycated haemoglobin (A1C) were randomised into intervention and usual care groups and followed for six months. Glycated haemoglobin analyzer, lipid analyzer and blood pressure monitor/apparatus were used to measure patients’ laboratory parameters at baseline and six months. Intervention group patients received pharmacist-structured care, made up of patient education and phone calls, in addition to usual care. In an intention to treat analysis, Mann-Whitney U test was used to compare median change at six months in the primary (A1C) and secondary outcome measures. Effect size was computed and proportion of patients that reached target laboratory parameters were compared in both arms. Results: All enrolled participants (108) completed the study, 54 in each arm. Mean age was 51 (SD 11.75) and majority were females (68.5%). Participants in the intervention group had significant reduction in A1C of -0.75%, compared with an increase of 0.15% in the usual care group (p<0.001; eta-square= 0.144). The proportion of those that achieved target A1C of <7% at 6 months in the intervention and usual care group was 42.6% vs 20.8% (p=0.02). Furthermore, intervention patients were about 3 times more likely to have better glucose control; A1C<7% (aOR 2.72, 95%CI: 1.14-6.46) compared to usual care group, adjusted for sex, age, and duration of diabetes. Conclusions: Pharmacist-led care significantly improved glycaemic control in patients with uncontrolled T2DM.

KEYWORDS

• Diabetes Mellitus, Type 2
• Glycemic Control
• Pharmacists
• Pharmaceutical Services
• Patient Education as Topic
• Blood Glucose
• Glycated Hemoglobin A
• Intention to Treat Analysis
• Randomized Controlled Trials as Topic
• Nigeria

Showing references and in-text citations exactly as published.

• DOI10.18549/PharmPract.2021.3.2402Copy

RELATED ARTICLES

Matched on section and article type within this issue of PP.

• Article · VOLUME 19, ISSUE 3Preferences based interventions to address the use of antibiotics without prescription: A discrete choice experimentJohanna Aponte-González, Paul Brown, Javier Eslava-Schmalbach · pp. 1Original ResearchSame type: Article
• Article · VOLUME 19, ISSUE 3Attitudes and beliefs of patients and primary caregivers towards deprescribing in a tertiary health care facilityNarayan Gaurang, Rajendran Priyadharsini, Kandan Balamurugesan, Mathiyalagen Prakash, Devanathan Reka · pp. 2350Original ResearchSame type: Article
• Article · VOLUME 19, ISSUE 3Treatment satisfaction and its association with anxiety, depression and fear of COVID-19 among Lebanese inpatients with schizophreniaZeinab Bitar, Chadia Haddad, Sahar Obeid, Souheil Hallit · pp. 2364Original ResearchSame type: Article
• Article · VOLUME 19, ISSUE 3Home medicines reviews: a national survey of Australian accredited pharmacists' health service time investmentMarea Patounas, Esther T. Lau, Vincent Chan, Deborah Rigby, Gregory J. Kyle, Jyoti Khatri, Arjun Poudel, Lisa M. Nissen · pp. 2376Original ResearchSame type: Article